Education, Science, Technology, Innovation and Life
Open Access
Sign In
  1. Home
  2. Journals
  3. MEDS Chinese Medicine
  4. Vol 5, Issue 10, 2023

Treatment of Amyotrophic Lateral Sclerosis from "Treating Wei and Taking Yang Ming Alone"

Download as PDF

DOI: 10.23977/medcm.2023.051023 | Downloads: 4 | Views: 242

Author(s)

Wanting Zhao 1, Bingcang Yan 2

Affiliation(s)

1 Shaanxi University of Chinese Medicine, Xianyang, Shaanxi 712046, China
2 Xi'an Traditional Chinese Medicine Encephalopathy Hospital, Xi'an, Shaanxi 710068, China

Corresponding Author

Bingcang Yan

ABSTRACT

Amyotrophic lateral sclerosis (amyotrophic lateral sclerosis) is a neurodegenerative disease with muscle weakness and muscle atrophy as the main clinical manifestations, which is similar in symptoms to the "Wei Zheng" of traditional Chinese medicine; so many doctors classify it as "Wei Zheng" in traditional Chinese medicine. The etiology and pathogenesis of amyotrophic lateral sclerosis are complex and diverse, Modern medicine believes that gene mutation plays a significant role in the pathogenesis of ALS, which is related to a variety of gene mutations, mainly superoxide dismutase 1 (SOD1), and the therapeutic effect of current modern medicine is still not significant. "Huangdi Neijing" put forward the treatment method of "Treating Wei and Taking Yang Ming Alone". Therefore, this paper attempts to treat amyotrophic lateral sclerosis from "Treating Wei and Taking Yang Ming Alone" by sorting out the relevant literature, and discusses the guiding significance of "Treating Wei and Taking Yang Ming Alone" on ALS, hoping to provide new ideas for traditional Chinese medicine treatment of ALS.

KEYWORDS

Amyotrophic Lateral Sclerosis, Wei Zheng, Treating Wei with Yangming Alone, Muscular Atrophy

CITE THIS PAPER

Wanting Zhao, Bingcang Yan, Treatment of Amyotrophic Lateral Sclerosis from "Treating Wei and Taking Yang Ming Alone". MEDS Chinese Medicine (2023) Vol. 5: 164-170. DOI: http://dx.doi.org/10.23977/medcm.2023.051023.

REFERENCES

[1] Li Yansheng, Huang Jian, Zhuang Jianhua, et al. Motor neurone disease. Shanghai: Second Military Medical University Press, 2002, 116-133.
[2] Miller R G, Mitchell J D, Lyon M, et al. Riluzole for amyotrophiclateral sclerosis(ALS)/motor neuron disease (MND). Ochrane Database SystRev, 2007, 1:D001447.
[3] Rothstein J D. Edaravone: A mew drug approved for ALS. Cell, 2017, 171(4): 725.
[4] Liu Xiangjing. Analysis on syndrome differentiation of five viscera flaccid syndrome of amyotrophic lateral sclerosis. Guangzhou University of Traditional Chinese Medicine, 2010.
[5] Zhang Boli, Wu Mianhua. Beijing: China Traditional Chinese Medicine Press, 2017.8.375.
[6] Traynor BJ, Codd MB, Corr B, et al. Incidence and prevalence of ALS in Ireland, 1995-1997: a population-based study. Neurology, 1999, 52(3):504-509.
[7] Wang Qingren. "Medical forest correction • paralysis theory" . Beijing: China Medical Science and Technology Press, 2011:41-46.
[8] Jia Jianping, Chen Shengdi. [M]. 8 edition. Beijing: People's Medical Publishing House, 2018:262.
[9] Gunnarsson L G, Bodin L. myotrophic lateral sclerosis and occupational exposures: a systematic literature review and meta-analyses. lnt J EnvironRes Public Health, 2018, 15(11):2371.
[10] Prasad A, Bharathi V, Sivalingam V, et al. Molecular mechanisms of TDP-43 misfolding and pathology in amyotrophic lateral sclerosis. Front Mol Neurosci, 2019, 12:25.
[11] Choi E S, Dokholyan N V. SOD1 oligomers in amyotrophic lateral sclerosis. Curr Opin Struct Biol, 2021, 66:225-230.
[12] Hayashi Y, Homma K, Ichijo H.Son1 in neurotoxicity and its controversial roles in SOD1 mutation-negative ALS. Adv Biol Regul, 2016, 60:95-104.
[13] Chen Zheng, Chen Huimin, Wang Kangjun, et al. Advances in treatment of amyotrophic lateral sclerosis. Modern Practical Medicine, 2013, 25(04):478-480.
[14] Ye Tianshi. Warm-heat Theory. Zhengzhou: Henan Science and Technology Press, 2017:1.
[15] Tian Daihua collated. Huang Di Nei Jing  Su Wen [M]. Beijing: People's Medical Publishing House, 2005.5:87.
[16] Zhang Jingyue. Jing Yue Complete Book. Chinese Medical Canon Changsha: Hunan Electronic Audio and Video Publishing House, 2006.
[17] Li Zhongzi. Zheng Zhi Hui Bu. Chinese Medical Code Changsha: Hunan Electronic Audio and Video Publishing House, 2006.
[18] Wang Shuangshuang, Xiaojun Yang, Tietao Deng, et al. Deng Tietao's experience in the treatment of amyotrophic lateral sclerosis. Journal of Guangzhou University of Traditional Chinese Medicine, 2010, 27(3):310-312.
[19] Jin Zikai, Guo Ziwei, Sun Meng, Jin Xiaoe, Niu Shuping, Tang Wei. Zhu Danxi's approach to the diagnosis and treatment of Wei Zheng. Chinese Journal of Basic TCM Medicine, 2021, 27(03):386-388.
[20] Xu Yunsheng. Deng Tietao teaches Gan Wen spleen strengthening method to treat difficult diseases. Sichuan Chinese Medicine, 2002; 20(3):1-2.
[21] Strickland D, Smith S A, Dolliff G, et al. Physical activity, trauma and ALS: a casecontrol study. Acta Neurol Scand, 1996(1):45.
[22] Yao X L, Zhang C, Wen L, et al. The diagnosis and etiology of amyotrophic lateral sclerosis. Chinese Journal of Neuropsychiatric Disorders, 2001, 27(3):18.
[23] Huang Y X, Lu Z Q, Guo Y J. Amyotrophic lateral sclerosis. Chinese General Clinic, 2003, 19(1):7.
[24] Liu Yue, Zhang Yunling. On "Treating flaccidity and taking Yangming Alone". Global Chinese Medicine, 2014, 7(9):713-715.
[25] Xue J, Liu G D. Medical Encyclopedia of the Four Great Doctors of Jin Yuan. Taiyuan: Shanxi Science and Technology Press, 2019:981.
[26] Cao J ZH, Wen C B. Analysis of "Treating flaccidity and taking Yangming alone" in impotence syndrome. World Latest Medical Information Digest,2018,18(92):205-206.

Subscription
E-Mail Alert
Most popular papers
Call for Special Issue
Publication Ethics & OA Statement
Plagiarism Policy
Contact Us
Downloads: 4224
Visits: 167401

Sponsors, Associates, and Links

All published work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright © 2016 - 2031 Clausius Scientific Press Inc. All Rights Reserved.